Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0019 | 0.9 |
mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.002 | 0.9 |
mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |